SCHEMBL13458535

SCHEMBL13458535

Bc1ccc(NC(=O)C(CCCN2C[C@@H]3C[C@H]2CO3)c2ccc(/C=C/C(=O)Nc3ccccc3NC(=O)OC(C)(C)C)cn2)cc1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CCNC P24863 2/20 0.37
▸ CDK8 P49336 2/20 0.37
▸ WNT3A P56704 6/20 0.33
▸ FLT3 P36888 2/20 0.31
▸ HDAC3 O15379 3/20 0.31
▸ HDAC1 Q13547 3/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31
▸ KDM1A O60341 1/20 0.31
▸ WNT1 P04628 3/20 0.31
▸ GSK3B P49841 3/20 0.31
▸ DYRK1A Q13627 3/20 0.31
▸ HDAC2 Q92769 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3234967 0.94 CCNC (0.37) CCNCCDK8WNT3AFLT3HDAC3
SCHEMBL3234953 0.94 CCNC (0.37) CCNCCDK8WNT3AFLT3HDAC3
SCHEMBL13458174 0.88 HDAC1 (0.42) CCNCCDK8HDAC3HDAC1HDAC8
SCHEMBL10039321 0.82 HDAC1 (0.41) CCNCCDK8HDAC3HDAC1HDAC8
SCHEMBL3225727 0.81 CCNC (0.37) CCNCCDK8FLT3HDAC3HDAC1
SCHEMBL3225738 0.81 CCNC (0.37) CCNCCDK8FLT3HDAC3HDAC1
SCHEMBL3226156 0.77 HDAC1 (0.44) HDAC3HDAC1KDM1AHDAC2
SCHEMBL3226196 0.77 HDAC1 (0.44) HDAC3HDAC1KDM1AHDAC2
SCHEMBL10039309 0.73 HDAC1 (0.44) CCNCCDK8HDAC3HDAC1HDAC8
SCHEMBL13458756 0.73 HDAC1 (0.45) CCNCCDK8HDAC3HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010031708-A2 NOVEL ORTHO-AMINOANILIDES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2010-03-25 — — WO disclosed
Send feedback